Literature DB >> 8606108

Fatty acid composition of the major phospholipids of Pneumocystic carinii: comparison with those in the lungs of normal and methylprednisolone-immunosuppressed rats.

Z Guo1, D H Beach, E S Kaneshiro.   

Abstract

Large numbers of viable organisms can be isolated from the corticosteroid-immunosuppressed rat model of Pneumocystis carinii pneumonia. With the development of purification protocols that provide organism preparations of high purity, meaningful lipid biochemical analyses of this important opportunistic pathogen can now be conducted. The phospholipid class composition of the pathogen was reported earlier, together with observations of changes that occur in the rat lungs in response to methylprednisolone immunosuppression treatment. In this report, analyses of the effects of corticosteroids on the fatty acid compositions of the major lung phospholipids, individually isolated and purified by thin-layer chromatography, were elucidated and quantified by gas-liquid chromatography. In response to methylprednisolone, there was a relative increase in palmitate and there were decreases in several unsaturated fatty acids of the rat whole-lung total polar lipids leading to a doubling of the saturation index. Reciprocal changes in the relative concentrations of palmitate and stearate in phosphatidylethanolamine, phosphatidylinositol, lysophosphatidylcholine, and cardiolipin were observed, suggesting that there is tight control of acylation of these phospholipids in the lung. Detailed phospholipid fatty acid analyses were also performed with mixed life cycle stages of P. carinii organisms. The most abundant phospholipids, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol, had much higher concentrations of oleic acid and lower concentrations of palmitate in P. carinii than in lung tissue. Sphingomyelin in lung tissue and P. carinii differed from the glycerophospholipids by the presence of high levels of saturated C(22) and C(24) fatty acids. This study represents the most comprehensive fatty acid analysis of rat lung phospholipids and the changes that occur in response to corticosteroid treatment. It is the first report about the fatty acids of individual phospholipids of the opportunistic protist P. carinii carinii.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606108      PMCID: PMC173933          DOI: 10.1128/iai.64.4.1407-1412.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Analyses of Pneumocystis fatty acids.

Authors:  E S Kaneshiro; M T Cushion; P D Walzer; K Jayasimhulu
Journal:  J Protozool       Date:  1989 Jan-Feb

Review 4.  Lung surfactant.

Authors:  J L Harwood
Journal:  Prog Lipid Res       Date:  1987       Impact factor: 16.195

5.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Positional distribution of fatty acids in the major glycerophospholipids of Paramecium tetraurelia.

Authors:  E S Kaneshiro
Journal:  J Lipid Res       Date:  1980-07       Impact factor: 5.922

7.  Evidence for the existence of ganglioside molecules on Pneumocystis carinii from human lungs.

Authors:  M Sorice; L Lenti; R Misasi; C Contini; L Cignarella; T Griggi; V Vullo; C Masala
Journal:  Parasitology       Date:  1992-08       Impact factor: 3.234

8.  Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

9.  Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.

Authors:  P M Sheehan; D C Stokes; Y Y Yeh; W T Hughes
Journal:  Am Rev Respir Dis       Date:  1986-09

10.  Preparation of sphingolipid fatty acid methyl esters for determination by gas-liquid chromatography.

Authors:  J MacGee; M G Williams
Journal:  J Chromatogr       Date:  1981-01-30
View more
  5 in total

1.  Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii.

Authors:  E S Kaneshiro; J E Ellis; Z Guo; K Jayasimhulu; J N Maiorano; K A Kallam
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Pneumocystis carinii pneumonia in scid mice induced by viable organisms propagated in vitro.

Authors:  J M Beck; R L Newbury; B E Palmer
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  C27 to C32 sterols found in Pneumocystis, an opportunistic pathogen of immunocompromised mammals.

Authors:  E S Kaneshiro; M A Wyder
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

Review 4.  The lipids of Pneumocystis carinii.

Authors:  E S Kaneshiro
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Sterol structure and sphingomyelin acyl chain length modulate lateral packing elasticity and detergent solubility in model membranes.

Authors:  Xin-Min Li; Maureen M Momsen; Howard L Brockman; Rhoderick E Brown
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.